| Literature DB >> 34527784 |
Hatice Demirağ1, Nurşen Kulakaç2, Sevilay Hintistan3, Dilek Çilingir4.
Abstract
OBJECTIVE: This study aims to determine the effects of cachexia, causing major problems in the world and Turkey, on self-care agency and quality of life in cancer patients.Entities:
Keywords: Cachexia; cancer; quality of life; self-care
Year: 2021 PMID: 34527784 PMCID: PMC8420915 DOI: 10.4103/apjon.apjon-2135
Source DB: PubMed Journal: Asia Pac J Oncol Nurs ISSN: 2347-5625
Figure 1Flow diagram of patient recruitment and tracking process and analysis set
Figure 2Flow chart showing the diagnosis of patients with and without cachexia. BMI: Body mass index.
Sociodemographic and clinical characteristics of the patients according to the groups (n=174)
| Variable | Cachexia ( | Noncachexia ( |
|
|---|---|---|---|
| Age (years), mean±SD | 51.60±9.30 | 54.35±11.22 | 0.121 |
| Gender | |||
| Female | 29 (55.8) | 44 (36.1) | 0.016 |
| Male | 23 (44.2) | 78 (63.9) | |
| Marital status | |||
| Married | 38 (73.1) | 85 (69.7) | 0.652 |
| Single | 14 (26.9) | 37 (30.3) | |
| Educational level | |||
| Primary school | 34 (65.4) | 85 (69.7) | 0.578 |
| High school and above | 18 (34.6) | 37 (30.3) | |
| Types of cancer | |||
| Lung | 2 (3.8) | 31 (25.4) | 0.852 |
| Digestive system | 32 (61.5) | 34 (27.9) | |
| Head-neck | 0 | 13 (10.7) | |
| Lymphoma | 8 (15.4) | 16 (13.1) | |
| Breast | 4 (7.7) | 8 (6.6) | |
| Gynecological | 3 (5.8) | 8 (6.6) | |
| Soft tissue tumor | 2 (3.8) | 8 (6.6) | |
| Other | 1 (1.9) | 4 (3.3) | |
| Stages of tumor | |||
| 1 | 0 | 15 (12.3) | <0.001 |
| 2 | 0 | 48 (39.3) | |
| 3 | 23 (44.2) | 33 (27.0) | |
| 4 | 29 (55.8) | 26 (21.3) | |
| Having surgery | |||
| Yes | 39 (75.0) | 36 (29.5) | <0.001 |
| No | 13 (25.0) | 86 (56.9) | |
| Receiving chemotherapy | |||
| Yes | 29 (55.8) | 83 (68.0) | 0.122 |
| No | 23 (44.2) | 39 (32.0) | |
| Receiving radiotherapy | |||
| Yes | 26 (50.0) | 42 (34.4) | 0.054 |
| No | 26 (50.0) | 80 (65.6) | |
| Receiving supportive treatment | |||
| Yes | 25 (48.1) | 25 (20.5) | <0.001 |
| No | 27 (51.9) | 97 (79.5) |
SD: Standard deviation
Self-care agency and quality of life of cachexia and noncachexia patients (n=174) (Mean±SD)
| Variable | Cachexia ( | Noncachexia ( |
|
|---|---|---|---|
| EORTC C30 cancer Quality of Life Scale | |||
| Functional Scale | 50.25±13.40 | 70.15±16.94 | <0.001 |
| Physical function | 50.86±13.60 | 70.00±17.20 | <0.001 |
| Role function | 48.79±17.19 | 70.79±18.71 | <0.001 |
| Emotional function | 50.24±13.38 | 70.08±17.10 | <0.001 |
| Cognitive function | 51.68±16.97 | 69.36±20.77 | <0.001 |
| Social function | 48.79±17.19 | 70.79±18.71 | <0.001 |
| Global State of Health Scale (general well-being) | 47.83±18.64 | 68.85±25.42 | <0.001 |
| Symptom Scale | 58.33±5.08 | 44.02±19.61 | <0.001 |
| Weakness | 86.05±7.14 | 63.72±16.52 | <0.001 |
| Nausea and vomiting | 81.00±8.39 | 62.50±15.74 | <0.001 |
| Pain | 86.29±11.93 | 67.62±43.91 | <0.001 |
| Dyspnea | 96.15±9.10 | 66.18±27.25 | <0.001 |
| Insomnia | 89.42±17.39 | 70.90±76.15 | 0.085 |
| Loss of appetite | 83.17±12.83 | 64.34±24.24 | <0.001 |
| Constipation | 96.15±9.10 | 66.18±27.25 | <0.001 |
| Diarrhea | 81.25±13.89 | 62.70±23.45 | <0.001 |
| Financial difficulty | 83.17±12.83 | 64.34±24.24 | <0.001 |
| Self-care agency scale | 23.55±12.78 | 76.71±41.66 | <0.001 |
SD: Standard deviation; EORTC: European Organization for Research and Treatment of Cancer
Relationship between some sociodemographic characteristics of the patients, self-care agency, quality of life and cachexia (n=174)
| Characteristics | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (1) Physical functions ( | 1 | |||||||||||
| (2) Role function ( | 0.822, <0.001 | 1 | ||||||||||
| (3) Emotional function ( | 0.998, <0.001 | 0.878, <0.001 | 1 | |||||||||
| (4) Cognitive function ( | 0.860, <0.001 | 0.546, <0.001 | 0.880, <0.001 | 1 | ||||||||
| (5) Social function ( | 0.896, <0.001 | 1.000, <0.001 | 0.878, <0.001 | 0.546, <0.001 | 1 | |||||||
| (6) General well-being ( | 0.710, <0.001 | 0.675, <0.001 | 0.704, <0.001 | 0.564, <0.001 | 0.675, <0.001 | 1 | ||||||
| (7) Symptom Scale ( | −0.633, <0.001 | −0.562, <0.001 | −0.637, <0.001 | −0.558, <0.001 | −0.562, <0.001 | −0.560, <0.001 | 1 | |||||
| (8) Self-care agency ( | 0.812, <0.001 | 0.721, <0.001 | 0.814, <0.001 | 0.710, <0.001 | 0.721, <0.001 | 0.741, <0.001 | −0.761, <0.001 | 1 | ||||
| (9) Stages of tumor ( | −0.810, <0.001 | −0.699, <0.001 | −0.816, <0.001 | −0.737, <0.001 | −0.699, <0.001 | −0.790, <0.001 | 0.747, <0.001 | −0.889, <0.001 | 1 | |||
| (10) Having surgery* (0=yes, 1=no) ( | 0.653, <0.001 | 0.603, <0.001 | 0.669, <0.001 | 0.574, <0.001 | 0.603, <0.001 | 0.573, <0.001 | −0.525, <0.001 | 0.693, <0.001 | −0.639, <0.001 | 1 | ||
| (11) Receiving supportive treatment* (0=yes, 1=no) ( | 0.702, <0.001 | 0.665, <0.001 | 0.709, <0.001 | 0.582, <0.001 | 0.665, <0.001 | 0.722, <0.001 | −0.520, <0.001 | 0.653, <0.001 | −0.721, <0.001 | 0.534, <0.001 | 1 | |
| (12) Cachexia* (0=cachexia, 1=noncachexia) ( | 0.598, <0.001 | 0.574, <0.001 | 0.611, <0.001 | 0.502, <0.001 | 0.574, <0.001 | 0.483, <0.001 | −0.506, <0.001 | 0.666, <0.001 | −0.554, <0.001 | 0.451, <0.001 | 0.364, <0.001 | 1 |
*A dummy variable is a variable that takes values of 0 and 1, where the values indicate the presence or absence of something
Associations between cachexia with self-care agency and quality of life (n=174)
| Model |
| SE | OR (95% CI) |
|
|---|---|---|---|---|
| Self-care agency | 0.056 | 0.014 | 1.058 (1.030-1.086) | <0.001 |
| Physical function | 0.075 | 0.165 | 1.078 (0.780-1.489) | 0.649 |
| Role function | 0.061 | 0.052 | 1.062 (0.959-1.177) | 0.245 |
| Social function | −0.115 | 0.214 | 0.892 (0.587-1.356) | 0.592 |
| Symptom scale | 0.015 | 0.017 | 1.016 (0.982-1.050) | 0.362 |
| General well-being | −0.023 | 0.015 | 0.977 (0.949-1.006) | 0.123 |
Dependent variable: Cachexia (0: Cachexia, 1: Noncachexia). Nagelkerke R2=0.502 Hosmer-Lemeshow=0.253. B: Unstandardised coefficient, SE: Standard error; OR: Odds ratio; CI: Confidence interval